BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 205771)

  • 1. Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3',5'-monophosphate.
    Hanley MR; Iversen LL
    Mol Pharmacol; 1978 Mar; 14(2):246-55. PubMed ID: 205771
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscarinic acetylcholine receptors and cyclic GMP in rat brain [proceedings].
    Hanley MR; Iversen LL
    Br J Pharmacol; 1977 Mar; 59(3):503P-504P. PubMed ID: 191132
    [No Abstract]   [Full Text] [Related]  

  • 3. [3H]-Quinuclidinyl benzilate binding to muscarinic receptors in rat brain: comparison of results from intact brain slices and homogenates.
    Gilbert RF; Hanley MR; Iversen LL
    Br J Pharmacol; 1979 Mar; 65(3):451-6. PubMed ID: 427318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic regulation of muscarinic receptor binding in the corpus striatum.
    Ehlert FJ; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1981; 24():93-5. PubMed ID: 7255494
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations of muscarinic cholinergic receptors in the rat striatum after kainic acid injections.
    Hruska RE; Schwarcz R; Coyle JT; Yamamura HI
    Brain Res; 1978 Sep; 152(3):620-5. PubMed ID: 687979
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease in (3H)-quinuclidinyl bezilate binding to the muscarinic cholinergic receptor in the longitudinal muscle of the rat ileum following chronic administration of diisopropylfuorophosphate.
    Ehlert FJ; Kokka N
    Proc West Pharmacol Soc; 1977; 20():1-7. PubMed ID: 896813
    [No Abstract]   [Full Text] [Related]  

  • 7. Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system?
    Marchi M; Paudice P; Gemignani A; Raiteri M
    J Neurosci Res; 1987; 17(2):142-5. PubMed ID: 2438426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractoriness to muscarinic and adrenergic agonists in the rat parotid: responses of adenosine and guanosine cyclic 3', 5'-monophosphates.
    Harper JF; Brooker G
    Mol Pharmacol; 1977 Nov; 13(6):1048-59. PubMed ID: 201829
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of striatal muscarinic receptors in vivo by cadmium.
    Hedlund B; Gamarra M; Bartfai T
    Brain Res; 1979 May; 168(1):216-8. PubMed ID: 110390
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical indentification of the mammalian muscarinic cholinergic receptor.
    Snyder SH; Chang KJ; Kuhar MJ; Yamamura HI
    Fed Proc; 1975 Sep; 34(10):1915-21. PubMed ID: 808430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscarinic receptors and their regulation of cyclic GMP in corneal endothelial cells.
    Walkenbach RJ; Ye GS
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):702-7. PubMed ID: 2159450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
    Keen M; Nahorski SR
    Mol Pharmacol; 1988 Dec; 34(6):769-78. PubMed ID: 3200249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic receptors in the mammalian central nervous system.
    Yamamura HI; Wastek G; Chang KJ; Snyder SH
    Proc West Pharmacol Soc; 1976; 19():13-8. PubMed ID: 995977
    [No Abstract]   [Full Text] [Related]  

  • 15. Striatal muscarinic receptors: regulation by dopaminergic agonists.
    Ehlert FJ; Roeske WR; Yamamura HI
    Life Sci; 1981 May; 28(21):2441-8. PubMed ID: 7253832
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
    Suga M
    Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
    Hruska RE; Ludmer LM; Pert A; Bunney WE
    J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue.
    Rosenberger LB; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1979 Jun; 56(1-2):179-80. PubMed ID: 467508
    [No Abstract]   [Full Text] [Related]  

  • 19. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
    Raiteri M; Leardi R; Marchi M
    J Pharmacol Exp Ther; 1984 Jan; 228(1):209-14. PubMed ID: 6141277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.